NAN FUNG TRINITY (HK) LTD
Position in BBIO — BridgeBio Pharma, Inc.
CIK 1781880
CENTRAL, HONG KONG, K3
Position in BBIO
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$16,278,905
+$7,857,356 QoQ
Shares Held
219,215
+99.1% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
2.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NAN FUNG TRINITY (HK) LTD holds $203,034,766 across 23 Biotechnology names. BBIO ranks #3 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
232,679 | $21,494,886 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
160,670 | $16,934,618 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
This page
|
219,215 | $16,278,905 | |
| 4 | IMNM |
Immunome Inc.
|
714,553 | $15,627,274 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
247,765 | $14,407,534 | |
| 6 | ABVX |
Abivax S.A.
|
128,940 | $14,357,469 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
285,495 | $14,034,934 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
1,142,950 | $13,635,393 |
All Filings in BBIO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,278,905 | 219,215 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $8,421,549 | 110,100 | Shares | Sole | 2026-02-04 | |
| No filing history on record for this holder in this stock. | ||||||